Anti-Sm and anti-RNP antibodies are crucial diagnostic markers in systemic autoimmune diseases, with distinct clinical associations regarding renal involvement and Raynaud's phenomenon.
No takes yet. Share an insight, caveat, or question.
Supports renal risk stratification via anti-Sm/RNP testing in SLE; leaves open validation in prospective cohorts.
Migliorini et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: